CNS RESP Chart calendar CNS RESP
b7e041a8b8f6ff3b22f463069c89.Oww_cFF8ysMUybF66PjzqYF3vjWbaj5YFsIZ0c0_5VA.djxaSAcjoPtVgdofgpag27VC6QP1EHIAbLd6pZ1G1z9zak0oGzSchX-k3g~a02f90f88f0be35611c277715c96633a
Upcoming events on CNS RESP
Past events on CNS RESP
| 09/05/2024 | Q1 2024 Earnings Release (Projected) |
| 14/11/2023 14:30 | Q3 2023 Earnings Release |
| 14/08/2023 20:54 | Q2 2023 Earnings Release |
| 15/05/2023 14:30 | Q1 2023 Earnings Release |
| 31/03/2023 21:15 | Q4 2022 Earnings Release |
| 08/12/2022 22:00 | Annual General Meeting |
| 14/11/2022 23:17 | Q3 2022 Earnings Release |
| 15/08/2022 21:30 | Interim 2022 Earnings Release |
| 23/06/2022 17:30 | OTC Markets Group Zacks Virtual Life Sciences Investor Conference |
| 24/05/2022 12:00 | H.C. Wainwright Global Life Sciences Investment Conference |
| 13/05/2022 13:23 | Q1 2022 Earnings Release |
| 03/05/2022 20:30 | Interim Investor Summit |
| 02/04/2022 | Meeting of the British Society for Haematology - E-Poster No.: BSH22- EP78 |
| 31/03/2022 22:24 | FY 2021 Earnings Release |
| 10/01/2022 12:00 | H.C. Wainwright BioConnect Conference |
| 16/12/2021 17:30 | OTC Markets Life Sciences Investor Forum |
| 13/12/2021 23:00 | American Society of Hematology Virtual Meeting and Exposition |
| 22/11/2021 | Annual General Meeting |
| 16/11/2021 19:00 | Investor Meeting |
| 12/11/2021 13:23 | Q3 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 20,6 23,0 -10.39% | 18,4 18,6 -1.18% |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -6,59 -5,40 -21.94% |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
|
Net income Million USD | Released Forecast Spread | 1,10 | 0,00 0,00 - | 0,00 0,00 - |
|
EPS USD | Released Forecast Spread | 0,02 | 0,00 0,00 - | 0,00 0,00 - |
| Announcement Date | 04/05/21 | 31/03/22 | 31/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,02 6,63 -54.46% | 3,23 6,00 -46.1% | 4,29 6,00 -28.55% | 4,94 6,00 -17.68% | 5,93 7,00 -15.29% | 6,75 5,00 35.06% |
|
EBIT Million USD | Released Forecast Spread | -4,97 2,25 -320.96% | |||||
| Announcement Date | 31/03/22 | 13/05/22 | 15/08/22 | 14/11/22 | 31/03/23 | 15/05/23 |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 06:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for CNS RESP
| 29/05/2024 21:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 14/05/2024 21:05 | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |